News: Johnson & Johnson
Updated: 367 hours and 41 minutes ago
This is the latest:
Johnson & Johnson Wins Over Longtime Holdout for Talc Settlement
Read: The Wall Street Journal
Johnson & Johnson says its ketamine-based drug can treat depression
Read: Quartz
Read: CNBC News
Johnson & Johnson's cancer drug Darzalex could replace Stelar as its best-seller
Read: Quartz
A group of cancer victims couldn't block Johnson & Johnson's $6.5 billion talc-powder settlement
Read: Quartz